MUC5B and xerostomia: MUC5B levels in submandibular gland saliva have showed a tendency to be higher among head and neck cancer patients who report no or mild xerostomia 12 months post treatment compared with patients with severe xerostomia who showed almost undetectable levels of MUC5B [27].